Smithsonian Magazine on MSN2d
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
The synthetic additive found in thousands of food products will now be phased out by 2027, but advocates say the agency's ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
FDA bans red food dye due to potential cancer risk
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...
US bans use of Red No.3 dye in food, drugs over potential cancer links
The U.S. on Wednesday banned the use of a synthetic food dye that gives some candies, cakes and certain oral medications a ...
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
FDA bans Red 3 food dye, citing cancer risk
The FDA has banned Red 3, a dye used in foods like candies and snack cakes, citing cancer risks observed in lab rats.
IJR4d
FDA Bans Cancer-Linked Food Dye Ahead Of RFK Jr’s Confirmation Hearing
The Food and Drug Administration (FDA) announced Wednesday it will ban Red No. 3, a common artificial food dye linked ...
FDA Bans Red No. 3 from Food and Drinks, Citing Cancer Risks
The artificial food dye can be found in candy, beverages, chips and other packaged foods — often consumed by children.
US FDA bans artificial food color Red No. 3 on links to cancer in rats
The U.S. Food and Drug Administration on Wednesday banned the use of Red No. 3, a synthetic food dye that gives some candies, ...
Food and Drug Administration moves to ban Red 3, citing concern over cancer in some animals
The FDA announced this week it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the ...
STAT19h
AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...